Srinivas Sowmiyanarayanan
Postgraduate AssociateAbout
Research
Publications
2026
Timing and Resolution of Bothersome Hot Flashes Following Short Course Oral Gonadotropin-Releasing Hormone Receptor Antagonist Relugolix, and Stereotactic Body Radiotherapy for Localized Prostate Cancer
Shah S, Nijhar S, Sowmiyanarayanan S, Anwar O, Pepin A, Danner M, Zwart A, Kumar D, Leger P, Dawson N, Suy S, Collins S. Timing and Resolution of Bothersome Hot Flashes Following Short Course Oral Gonadotropin-Releasing Hormone Receptor Antagonist Relugolix, and Stereotactic Body Radiotherapy for Localized Prostate Cancer. Cureus 2026, 18: e104069. PMID: 41883889, PMCID: PMC13012396, DOI: 10.7759/cureus.104069.Peer-Reviewed Original ResearchStereotactic body radiotherapyPost-SBRTAndrogen deprivation therapyLocalized prostate cancerTestosterone recoveryBothersome hot flashesHot flashesProstate cancerShort courseOral gonadotropin-releasing hormoneProstate stereotactic body radiotherapyRobotic stereotactic body radiotherapyLocalized prostate cancer patientsExpanded Prostate Index CompositeProstate Index CompositeMedStar Georgetown University HospitalProstate cancer patientsTotal testosterone levelsFollow-up visitGeorgetown University HospitalHot flash scoreGonadotropin-releasing hormoneAccuray Inc.SBRT treatmentDeprivation therapy
2025
Cardiovascular health and gender minority stress in transgender and gender diverse adults: A cross-sectional study
Sowmiyanarayanan S, Karsan R, Deppe W, Binongo J, Tangpricha V. Cardiovascular health and gender minority stress in transgender and gender diverse adults: A cross-sectional study. The American Journal Of The Medical Sciences 2025, 370: 445-451. PMID: 40774383, DOI: 10.1016/j.amjms.2025.08.008.Peer-Reviewed Original ResearchConceptsLife's Essential 8Life's Essential 8 scoreGender minority stressBody mass indexCardiovascular healthPhysical activityTGD adultsMedical recordsUniversity Institutional Review BoardElectronic medical recordsCross-sectional studyQuality of lifeUnited States populationMinority stressDiverse adultsEndocrinology outpatient clinicIncomplete questionnairesSub scoresOutpatient clinicTGD individualsMass indexGender diverse adultsAdult populationObservational studyEssential 8
2024
Stereotactic Body Radiation Therapy for Clinically Localized Prostate Cancer in Men With Hip Prostheses: A Cautionary Note
Shah S, Saravanakumar S, Conroy D, Sowmiyanarayanan S, Singh R, Pepin A, Rashid H, Danner M, Krishnan P, Lei S, Rashid A, Suy S, Kataria S, Aghdam N, Collins S. Stereotactic Body Radiation Therapy for Clinically Localized Prostate Cancer in Men With Hip Prostheses: A Cautionary Note. Cureus 2024, 16: e61432. PMID: 38947568, PMCID: PMC11214744, DOI: 10.7759/cureus.61432.Peer-Reviewed Original ResearchStereotactic body radiation therapyProstate stereotactic body radiation therapyTreated with stereotactic body radiation therapyLocalized prostate cancerLocal recurrenceProstate cancerLate toxicityRadiation therapyEfficacy of stereotactic body radiation therapyCommon Terminology Criteria for Adverse Events versionGrade 2 GI toxicityGrade 3 GU toxicityRates of late toxicityRisk of late toxicityTreatment planningClinically localized prostate cancerDose calculation algorithmAdverse Events versionHigh-grade toxicityMedian Follow-UpMedStar Georgetown University HospitalSingle-institution studyCohort of patientsElevated riskRadiation dose calculations